About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cardiovascular Prevention and Pharmacotherapy
›
Top Articles
Cardiovascular Prevention and Pharmacotherapy
0.3
(top 100%)
impact factor
61
(top 100%)
papers
33
(top 100%)
citations
2
(top 100%)
h
-index
0.3
(top 100%)
impact factor
87
all documents
43
doc citations
5
(top 100%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Update on the Pharmacotherapy of Heart Failure with Reduced Ejection Fraction
Cardiovascular Prevention and Pharmacotherapy
2020
12
2
Recent Technology-Driven Advancements in Cardiovascular Disease Prevention in Korea
Cardiovascular Prevention and Pharmacotherapy
2019
3
3
Methods for Evaluating the Accuracy of Diagnostic Tests
Cardiovascular Prevention and Pharmacotherapy
2021
2
4
Aspirin Has a Neutral Effect in Preventing Future Cardiovascular Events in Vasospastic Angina
Cardiovascular Prevention and Pharmacotherapy
2019
2
5
Challenges and Future in Precision Cardiovascular Medicine
Cardiovascular Prevention and Pharmacotherapy
2019
2
6
Competing Risk Model in Survival Analysis
Cardiovascular Prevention and Pharmacotherapy
2020
2
7
Geriatric Considerations in the Management of Elderly Patients with Cardiovascular Diseases
Cardiovascular Prevention and Pharmacotherapy
2021
1
8
Tafamidis for Cardiac Transthyretin Amyloidosis
Cardiovascular Prevention and Pharmacotherapy
2021
1
9
Inflammation in Metabolic Diseases and Insulin Resistance
Cardiovascular Prevention and Pharmacotherapy
2021
1
10
Logistic Regression and Least Absolute Shrinkage and Selection Operator
Cardiovascular Prevention and Pharmacotherapy
2020
1
11
Effects of Low-Carbohydrate, High-Fat Diets on Weight Loss, Cardiovascular Health and Mortality
Cardiovascular Prevention and Pharmacotherapy
2020
1
12
Improving Causal Inference in Observational Studies: Propensity Score Matching
Cardiovascular Prevention and Pharmacotherapy
2019
1
13
Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention
Cardiovascular Prevention and Pharmacotherapy
2019
1
14
Asian Cohort Studies on Cardiovascular Risk Factors in Childhood
Cardiovascular Prevention and Pharmacotherapy
2019
1
15
Body Weight Change and Cardiovascular Disease: Effect of Weight Gain, Weight Loss, and Weight Cycling
Cardiovascular Prevention and Pharmacotherapy
2021
1
16
Changes in Target Achievement Rates after Statin Prescription Changes at a Single University Hospital
Cardiovascular Prevention and Pharmacotherapy
2020
1
17
Pragmatic Clinical Trials for Real-World Evidence: Concept and Implementation
Cardiovascular Prevention and Pharmacotherapy
2020
1
18
Shifting from Pharmacotherapy to Prevention of Hypertension
Cardiovascular Prevention and Pharmacotherapy
2020
1
19
Effects of physical activity on cardiovascular outcomes and mortality in Korean patients with diabetes: a nationwide population-based cohort study
Cardiovascular Prevention and Pharmacotherapy
2022
1
20
Safety and efficacy of low-dose aspirin in patients with coronary artery spasm: long-term clinical follow-up
Cardiovascular Prevention and Pharmacotherapy
2022
1
21
Adverse effects of statin therapy and their treatment
Cardiovascular Prevention and Pharmacotherapy
2022
1
22
Targets for rescue from fatty acid-induced lipotoxicity in pancreatic beta cells
Cardiovascular Prevention and Pharmacotherapy
2022
1
23
Development of a predictive model for the side effects of liraglutide
Cardiovascular Prevention and Pharmacotherapy
2022
1
24
Blood pressure control in hypertensive disorders of pregnancy
Cardiovascular Prevention and Pharmacotherapy
2022
1
25
Changes in cardiovascular-related health behaviors during the COVID-19 pandemic
Cardiovascular Prevention and Pharmacotherapy
2023
1
26
Vasopressin Receptor Antagonist, Tolvaptan, for Treating Hyponatremia in Patients with Heart Failure
Cardiovascular Prevention and Pharmacotherapy
2021
0
27
Perioperative Management of Hypertensive Patients
Cardiovascular Prevention and Pharmacotherapy
0
0
28
Perceptron: Basic Principles of Deep Neural Networks
Cardiovascular Prevention and Pharmacotherapy
0
0
29
Diabetes and Heart Failure
Cardiovascular Prevention and Pharmacotherapy
2021
0
30
Characteristics of Patients with Vasospastic Angina in Korea: Data from a Large Cohort (VA-KOREA)
Cardiovascular Prevention and Pharmacotherapy
0
0
31
Preterm Labor and Later Maternal Cardiovascular Disease in General Population: Doubtful Relationship with Atherosclerosis
Cardiovascular Prevention and Pharmacotherapy
2019
0
32
Welcome to the New JournalCardiovascular Prevention and Pharmacotherapy
Cardiovascular Prevention and Pharmacotherapy
2019
0
33
CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel
Cardiovascular Prevention and Pharmacotherapy
2019
0
34
Pregnancy at Late Maternal Age and Future Cardiovascular Health
Cardiovascular Prevention and Pharmacotherapy
2019
0
35
CHA2DS2-VASc Score Is Correlated with Cardiac Performance in Chronic Atrial Fibrillation
Cardiovascular Prevention and Pharmacotherapy
2020
0
36
Improving Causal Inference in Observational Studies: Interrupted Time Series Design
Cardiovascular Prevention and Pharmacotherapy
2020
0
37
Basic Concepts of a Mendelian Randomization Approach
Cardiovascular Prevention and Pharmacotherapy
2020
0
38
Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's Perspective
Cardiovascular Prevention and Pharmacotherapy
2020
0
39
Relationship between Retinal nerve Fiber Layer Defects and Coronary Artery Calcium Score in Patients at Risk for Cardiovascular Disease
Cardiovascular Prevention and Pharmacotherapy
2021
0
40
Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It
Cardiovascular Prevention and Pharmacotherapy
2021
0
41
Dose Selection of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Non-Valvular Atrial Fibrillation
Cardiovascular Prevention and Pharmacotherapy
2020
0
42
Prevention of Type 2 Diabetes
Cardiovascular Prevention and Pharmacotherapy
2020
0
43
Causal Claims in Health Sciences and Medicine: a Difference-in-Differences Method
Cardiovascular Prevention and Pharmacotherapy
2020
0
44
From Traditional Statistical Methods to Machine and Deep Learning for Prediction Models
Cardiovascular Prevention and Pharmacotherapy
2020
0
45
Barriers in Salt Reduction Strategies: Time to Acting for the Future
Cardiovascular Prevention and Pharmacotherapy
2020
0
46
Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
Cardiovascular Prevention and Pharmacotherapy
2021
0
47
Diabetes in People with Disabilities: a Call for Action
Cardiovascular Prevention and Pharmacotherapy
2021
0
48
Modeling of Changes in Creatine Kinase after HMG-CoA Reductase Inhibitor Prescription
Cardiovascular Prevention and Pharmacotherapy
2021
0
49
Association between Myocardial Infarction Location and In-Hospital Mortality in Iran: A Nationwide Study
Cardiovascular Prevention and Pharmacotherapy
2021
0
50
Anti-inflammatory effects of colchicine on coronary artery disease
Cardiovascular Prevention and Pharmacotherapy
2022
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.